Current Edition


Participation in clinical trials may eliminate ovarian cancer survival disparities

Improving the diversity of enrollment in clinical trials may improve health disparities among women with ovarian cancer, according to study results presented at the S...
Continue Reading →

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient to a Phase II study testing DCVAC/OvCa in combination with ...
Continue Reading →